Unmet needs in hypertension: Challenges and opportunities

Current Hypertension Reports

Volumn 1, Issue 6, 1999, Pages 495-501

  Jackson, Joseph D ^a   Merat, Patrick ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE; HEALTH; HEALTH SERVICE; HEALTH SURVEY; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PHYSIOLOGY; PUBLIC HEALTH; RISK FACTOR;

BLOOD PRESSURE; HEALTH SERVICES NEEDS AND DEMAND; HEALTH STATUS INDICATORS; HUMANS; HYPERTENSION; PATIENT COMPLIANCE; PUBLIC HEALTH; RISK FACTORS; WORLD HEALTH;

EID: 0033291963     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-996-0021-z     Document Type: Article

References (47)

1. Meissner I, Whisnant J P, Sheps SG, et al.: Detection and control of high blood pressure in the community: Do we need a wake up call? Hypertension 1999, 34:466-471.
2. Hiatt H, Goldman L: Making medicine more scientific [editorial]. Nature 1994, 371:100.
3. Murray C J L, Lopez AD: Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996, 274:740-743.
4. Murray CJL, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997, 349:1269-1276.
5. Murray CJL, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
6. Murray CJL, Lopez AD: Global mortality, disability, and the contribution of risk factor: Global Burden of Disease Study. Lancet 1997, 349:1436-1442.
7. Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999, 17:151-183.
8. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med 1997, 157:2413-2446.
9. Zanchetti A: Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents. J Hypertens 1995, 13(suppl 2):119-122.
10. Alli C, Avanzini F, Giueseppe B, et al.: The long term prognostic significance of repeated blood pressure measurements in the elderly, Studio sulla Pressione Arteriosa nell'Anziano 10 year follow up. Arch Intern Med 1999, 159:1205-1212.
11. O'Donnell CJ, Kannel WB: Cardiovascular risks of hypertension: lessons from observational studies. J Hypertens 1998, 16(suppl 6):3-7.
12. Staessen JA, Thijs L, Gasowski J, et al.: Treatment of isolated systolic hypertension in the elderly: further evidence from the Systolic Hypertension in Europe (Syst-Eur) Trial. Am J Cardiol 1998, 82:20R-22R.
13. Mitchell G F, Moye LA, Braunwald E, et al.: Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Circulation 1997, 96:4254-4260.
14. Benetos A, Safar M, Rudnichi A, et al.: Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997, 30:1410-1415.
15. Franklin SS, Khan SA, Wong ND, et al.: Is pulse pressure more important than systolic blood pressure in predicting coronary heart disease events? The Framingham Heart Study [abstract]. Circulation 1998, 98(suppl I):324.
16. Fang J, Madhaven S, Cohen H, Alderman MH: Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens 1995, 13:413-419.
17. Lapuerta P, L'Italien GJ: Awareness, treatment and control of systolic blood pressure in the United States [abstract]. Am J Hypertens 1999, 12:92A.
18. Curb JD, Aluli NE, Huang BJ, et al.: Hypertension in elderly Japanese Americans and adult native Hawaiians. Public Health Rep 1996, 111(suppl 2):53-55.
19. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316, 099 white men. Arch Intern Med 1992, 152:56-64.
20. Elliott WJ: Which blood pressure measurement is more important in the elderly? Arch Intern Med 1999, 159:1165-1166.
21. Franklin SS: Is pulse pressure useful in predicting risk for coronary heart disease? Circulation 1999, 100:354-360.
22. Berlowitz DR, Ash AS, Hickey EC, et al.: Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998, 339:1957-1963.
23. Collins R, Peto R, MacMahon S, et al.: Blood pressure, stroke and coronary heart disease II: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990, 335:827-838.
24. Mulrow CD, Cornell JA, Herrera CR, et al.: Hypertension in the elderly: implications and generalizability of randomize trials. JAMA 1994, 272:1932-1938.
25. Staessen JA, Thijs L, Birkenhager WH, et al.: Update on the Systolic Hypertension in Europe (Syst-Eur) Trial. Hypertension 1999, 33:1476-1477.
26. Black HR: The paradigm has shifted, to systolic blood pressure. Hypertension 1999, 34:1-2.
27. Cushman WC: The clinical significance of systolic hypertension. Am J Hypertens 1998, 11:S182-S185.
28. Tobian L, Brunner HR, Cohn JN, et al.: A group of experts convened by the President of the American Society of Hypertension to express their individual opinions. Am J Hypertens 1994, 7:859-872.
29. Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the US adult population. Hypertension 1995, 25:305-313.
30. Rosenblatt RA, Cherkin DC, Schneeweiss R, Hart LG: The content of ambulatory medical care in the United States: an interspecialty comparison. N Engl J Med 1983, 309:892-897.
31. Marques-Vidal P: Sex differences in awareness and control of hypertension in France. J Hypertens 1997, 15:1205-1210.
32. Faulhaber HD: Treatment of high blood pressure in Germany. Am J Hypertens 1998, 11:750-753.
33. Colhoun HM, Dong W, Poulter NR: Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998, 16:747-752.
34. Stamler J: Blood pressure and high blood pressure. Hypertension 1991, 18(suppl 3):95-107.
35. Rogers PG, Bullman WR: Prescription medicine compliance: a review of the baseline knowledge: a report of the National Council on Patient Information and Education. J Pharmacoepidemiol 1995, 2:3-36.
36. Sackett DL, Haynes RB, eds.: Compliance with Therapeutic Regimens. Baltimore: Johns Hopkins University Press; 1976.
37. Haynes RB, Gibson ES, Taylor W, et al.: Process versus outcome in hypertension: a positive result. Circulation 1982, 65:28-33.
38. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264.
39. Hansson L, Zanchetti A, Carruthers SG, et al.: Effects o intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998, 351:1755-1762.
40. Roter DL, Hall JA, Merisca R, et al.: Effectiveness of interventions to improve patient compliance. Med Care 1998, 36:1138-1161.
41. Caro JJ, Salas M, Speckman JL, et al.: Persistence with treatment for hypertension in actual practice. Can Med Assoc J 1999, 160:31-37.
42. Caro JJ, Speckman JL, Salas M, et al.: Effect of initial drug choice on persistence with anti-hypertensive therapy: the importance of actual practice data. Can Med Assoc J 1999, 160:41-46.
43. Monane M, Bohn RL, Gurwitz JH, et al.: The effects of initial drug choice and comorbidity in antihypertensive therapy compliance. Am J Hypertens 1997, 10:697-704.
44. Bloom BS: Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998, 20:671-681.
45. Jones JK, Gorkin L, Lian JF, et al.: Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BJM 1995, 311:293-295.
46. Stockwell DH, Madhaven S, Cohen H, et al.: The determination of hypertension awareness, treatment and control in an insured population. Am J Public Health 1994, 84:1768-1774.
47. McCombs JS, Nichol MB, Newman CM, Sclar DA: The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care 1994, 32:214-226.